Next 10 |
2024-03-28 13:46:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...
2024-03-28 10:31:43 ET Summary Teladoc Health, Inc. has experienced a post-Covid hangover, with the shares losing more than 90% since peaking early in 2021. Despite the decline, the company is generating substantial free cash flow. Can Teladoc Health and its stock regain some ...
2024-03-24 22:38:39 ET Summary Teladoc's revenue grew 8% YoY to $2.6B and Adjusted EBITDA grew 33% YoY to $328M, but investors are concerned about the slowdown in revenue growth. The company is focused on improving profitability and has seen growth in Adjusted EBITDA and margins i...
2024-03-12 16:33:15 ET Summary Hims & Hers Health, Inc. has grown from a startup ($82m revenues in 2019) to a multi-billion-dollar company ($872m revenues in 2023) with more than 1.5 million subscribers; showcasing its scalability and product development. Hims & Hers Healt...
2024-03-11 03:30:00 ET The struggle continues for telemedicine specialist Teladoc (NYSE: TDOC) . The company's shares have been in free-fall since 2021 -- down 90% over the past three years -- and it started 2024 with another disappointing quarterly update that further dragged down ...
2024-03-10 03:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-09 10:30:00 ET The telehealth industry took off during the early stages of the pandemic when it was pivotal for patients to be able to access remote care easily. But a big assumption many investors have made is that the growth won't be as promising now that things have largely retur...
PURCHASE, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (G...
2024-03-01 07:56:00 ET Teladoc Health (NYSE: TDOC) is coming off another earnings performance in which the business made incremental improvements, but not quite enough to make Wall Street happy. And so down the stock went, crashing to new lows. It's unfortunately a normal cycle that...
2024-02-23 12:59:36 ET Shares of Teladoc Health (NYSE: TDOC) collapsed over 30% this week, according to data from S&P Global Market Intelligence . The telehealth provider posted weak revenue growth, more operating losses, and bad 2024 guidance in its 2023 earnings releas...
News, Short Squeeze, Breakout and More Instantly...
2024-03-11 03:30:00 ET The struggle continues for telemedicine specialist Teladoc (NYSE: TDOC) . The company's shares have been in free-fall since 2021 -- down 90% over the past three years -- and it started 2024 with another disappointing quarterly update that further dragged down ...
2024-03-10 03:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-09 10:30:00 ET The telehealth industry took off during the early stages of the pandemic when it was pivotal for patients to be able to access remote care easily. But a big assumption many investors have made is that the growth won't be as promising now that things have largely retur...